At a glance
- Originator Roche Palo Alto LLC
- Class Antihypertensives; Vasodilators
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 28 Feb 1995 Discontinued-Unspecified phase in Hypertension in USA (Unknown route)